Literature DB >> 11462044

Effective human herpesvirus 8 infection of human umbilical vein endothelial cells by cell-mediated transmission.

S Sakurada1, H Katano, T Sata, H Ohkuni, T Watanabe, S Mori.   

Abstract

Cell-free transmission of human herpesvirus 8 (HHV-8) to human cells in vitro has been reported to be difficult, if not impossible. The present experiments were conducted with the idea that cell-cell contact may produce much more effective transmission, so-called cell-mediated transmission. Primary human umbilical vein endothelial cells (HUVECs) were cocultured with an HHV-8-infected lymphoma cell line, BCBL-1 cells. When a ratio of 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated BCBL-1 cells to HUVECs of 10:1 was used, more than 20% of HUVECs were found to express the HHV-8 latency-associated nuclear antigen (LANA) 48 h after the start of coculturing; this value increased to more than 30% after 72 h. HHV-8-encoded ORF26, K8, K8.1, K10, K11, ORF59, and ORF65 proteins were not detected in these HHV-8-infected HUVECs until 72 h. The HHV-8 antigens were not observed in HUVECs cocultured with TPA-treated BCBL-1 cells separated by a membrane. Thirty days after removal of the BCBL-1 cells from the cell-mediated transmission experiment, the HUVECs still expressed LANA and the HHV-8 genome was detected by PCR in these cells. Moreover, the ORF59 protein, a DNA replication-associated protein of HHV-8, was expressed in such HUVECs in the presence of TPA stimulation. These results indicated a far more effective transmission mechanism, cell-cell contact, suggesting the possibility that such a mechanism works in vivo.

Entities:  

Mesh:

Year:  2001        PMID: 11462044      PMCID: PMC115007          DOI: 10.1128/JVI.75.16.7717-7722.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  p53 inhibition by the LANA protein of KSHV protects against cell death.

Authors:  J Friborg; W Kong; M O Hottiger; G J Nabel
Journal:  Nature       Date:  1999 Dec 23-30       Impact factor: 49.962

2.  Culture and properties of cells derived from Kaposi sarcoma.

Authors:  J Corbeil; L A Evans; E Vasak; D A Cooper; R Penny
Journal:  J Immunol       Date:  1991-05-01       Impact factor: 5.422

3.  Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.

Authors:  C Parravicini; B Chandran; M Corbellino; E Berti; M Paulli; P S Moore; Y Chang
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

4.  AIDS-related Kaposi's sarcoma displays differential expression of endothelial surface antigens.

Authors:  P A Scully; H K Steinman; C Kennedy; K Trueblood; D M Frisman; J R Voland
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

5.  Evidence for the origin of Kaposi's sarcoma from lymphatic endothelium.

Authors:  J H Beckstead; G S Wood; V Fletcher
Journal:  Am J Pathol       Date:  1985-05       Impact factor: 4.307

6.  Human herpesvirus type 8 DNA sequences in cell-free plasma and mononuclear cells of Kaposi's sarcoma patients.

Authors:  W J Harrington; O Bagasra; C E Sosa; L E Bobroski; M Baum; X L Wen; L Cabral; G E Byrne; R J Pomerantz; C Wood
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

7.  Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi's sarcoma.

Authors:  H Katano; T Iwasaki; N Baba; M Terai; S Mori; A Iwamoto; T Kurata; T Sata
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

8.  Cultured, AIDS-related Kaposi's sarcoma cells express endothelial cell markers and are weakly malignant in vitro.

Authors:  W K Roth; S Werner; W Risau; K Remberger; P H Hofschneider
Journal:  Int J Cancer       Date:  1988-11-15       Impact factor: 7.396

9.  Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro.

Authors:  S Z Salahuddin; S Nakamura; P Biberfeld; M H Kaplan; P D Markham; L Larsson; R C Gallo
Journal:  Science       Date:  1988-10-21       Impact factor: 47.728

10.  Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SCID-hu Thy/Liv mice.

Authors:  D Dittmer; C Stoddart; R Renne; V Linquist-Stepps; M E Moreno; C Bare; J M McCune; D Ganem
Journal:  J Exp Med       Date:  1999-12-20       Impact factor: 14.307

View more
  17 in total

1.  Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen prolongs the life span of primary human umbilical vein endothelial cells.

Authors:  Takahiro Watanabe; Makoto Sugaya; April M Atkins; Elisabeth A Aquilino; Aparche Yang; Debra L Borris; John Brady; Andrew Blauvelt
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

2.  Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells.

Authors:  Jill T Bechtel; Yuying Liang; Joshua Hvidding; Don Ganem
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

3.  Functional divergence of Kaposi's sarcoma-associated herpesvirus and related gamma-2 herpesvirus thymidine kinases: novel cytoplasmic phosphoproteins that alter cellular morphology and disrupt adhesion.

Authors:  Michael B Gill; Jo-Ellen Murphy; Joyce D Fingeroth
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Human herpesvirus-8 infection of primary pulmonary microvascular endothelial cells.

Authors:  Todd M Bull; Christina A Meadows; Christopher D Coldren; Mark Moore; Sylk M Sotto-Santiago; Serge P Nana-Sinkam; Thomas B Campbell; Mark W Geraci
Journal:  Am J Respir Cell Mol Biol       Date:  2008-06-27       Impact factor: 6.914

5.  Whole-genome transcription profiling of rhesus monkey rhadinovirus.

Authors:  Dirk P Dittmer; Carlos M Gonzalez; Wolfgang Vahrson; Scott M DeWire; Rebecca Hines-Boykin; Blossom Damania
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  Infection of lymphoblastoid cell lines by Kaposi's sarcoma-associated herpesvirus: critical role of cell-associated virus.

Authors:  Jinjong Myoung; Don Ganem
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

Review 7.  Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.

Authors:  Lyubomir A Dourmishev; Assen L Dourmishev; Diana Palmeri; Robert A Schwartz; David M Lukac
Journal:  Microbiol Mol Biol Rev       Date:  2003-06       Impact factor: 11.056

8.  The latency-associated nuclear antigen of rhesus monkey rhadinovirus inhibits viral replication through repression of Orf50/Rta transcriptional activation.

Authors:  Scott M DeWire; Blossom Damania
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

9.  Surface downregulation of major histocompatibility complex class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus.

Authors:  Costin Tomescu; Wai K Law; Dean H Kedes
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

10.  Disruption of LANA in rhesus rhadinovirus generates a highly lytic recombinant virus.

Authors:  Kwun Wah Wen; Dirk P Dittmer; Blossom Damania
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.